These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22593588)

  • 1. Parental origin of the X-chromosome does not influence growth hormone treatment effect in Turner syndrome.
    Devernay M; Bolca D; Kerdjana L; Aboura A; Gérard B; Tabet AC; Benzacken B; Ecosse E; Coste J; Carel JC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1241-8. PubMed ID: 22593588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of parental origin of the X chromosome on physical phenotypes and GH responsiveness of patients with Turner syndrome.
    Ko JM; Kim JM; Kim GH; Lee BH; Yoo HW
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):66-71. PubMed ID: 20148908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of the parental origin of the X chromosome in turner syndrome.
    Sagi L; Zuckerman-Levin N; Gawlik A; Ghizzoni L; Buyukgebiz A; Rakover Y; Bistritzer T; Admoni O; Vottero A; Baruch O; Fares F; Malecka-Tendera E; Hochberg Z
    J Clin Endocrinol Metab; 2007 Mar; 92(3):846-52. PubMed ID: 17192299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic imprinting in Turner syndrome: effects on response to growth hormone and on risk of sensorineural hearing loss.
    Hamelin CE; Anglin G; Quigley CA; Deal CL
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3002-10. PubMed ID: 16757526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome.
    Fiot E; Zenaty D; Boizeau P; Haigneré J; Dos Santos S; Léger J;
    Eur J Endocrinol; 2016 Mar; 174(3):281-8. PubMed ID: 26744895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of parental origin of X chromosome genes on the stature of patients with 45 X Turner syndrome.
    Kochi C; Longui CA; Lemos-Marini SH; Guerra-Junior G; Melo MB; Calliari LE; Monte O
    Genet Mol Res; 2007 Jan; 6(1):1-7. PubMed ID: 17278084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
    Ranke MB; Lindberg A; Ferrández Longás A; Darendeliler F; Albertsson-Wikland K; Dunger D; Cutfield WS; Tauber M; Wilton P; Wollmann HA; Reiter EO;
    Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment.
    Cleemann Wang A; Hagen CP; Nedaeifard L; Juul A; Jensen RB
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32421787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of parental origin of X-chromosome on clinical and biochemical profile in Turner syndrome.
    Malhotra R; Shukla R; Kabra M; Gupta Y; Jyotsna VP; Khadgawat R
    J Pediatr Endocrinol Metab; 2020 Sep; 33(9):1155-1163. PubMed ID: 32813677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
    Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of patient characteristics and clinical factors on the decision to initiate growth hormone treatment in Turner syndrome.
    Khatchadourian K; Huot C; Alos N; Van Vliet G; Deal C
    Horm Res; 2008; 70(5):300-8. PubMed ID: 18824869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial.
    Blum WF; Ross JL; Zimmermann AG; Quigley CA; Child CJ; Kalifa G; Deal C; Drop SL; Rappold G; Cutler GB
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1383-92. PubMed ID: 23720786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
    Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.
    Quigley CA; Crowe BJ; Anglin DG; Chipman JJ
    J Clin Endocrinol Metab; 2002 May; 87(5):2033-41. PubMed ID: 11994337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parental origin and mechanism of formation of a 46,X,der(X)(pter-->q21.1::p11.4-->pter)/45,X karyotype in a woman with mild Turner syndrome.
    Binkert F; Spreiz A; Höckner M; Miny P; von Dach Leu B; Erdel M; Zschocke J; Utermann G; Kotzot D
    Fertil Steril; 2010 Jun; 94(1):350.e12-5. PubMed ID: 20117774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Turner's syndrome by molecular analysis of the X chromosome in growth-retarded girls.
    Gicquel C; Gaston V; Cabrol S; Le Bouc Y
    J Clin Endocrinol Metab; 1998 May; 83(5):1472-6. PubMed ID: 9589641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.